Harbor Capital Advisors’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23K | Buy |
1,325
+869
| +191% | +$15.1K | ﹤0.01% | 784 |
|
|
2025
Q1 | $29K | Sell |
456
-1,250
| -73% | -$79.5K | ﹤0.01% | 763 |
|
|
2024
Q4 | $207K | Buy |
1,706
+427
| +33% | +$51.8K | 0.01% | 655 |
|
|
2024
Q3 | $160K | Buy |
1,279
+6
| +0.5% | +$751 | 0.01% | 693 |
|
|
2024
Q2 | $201K | Sell |
1,273
-77
| -6% | -$12.2K | 0.02% | 640 |
|
|
2024
Q1 | $175K | Sell |
1,350
-440
| -25% | -$57K | 0.02% | 640 |
|
|
2023
Q4 | $173K | Sell |
1,790
-1,454
| -45% | -$140K | 0.03% | 371 |
|
|
2023
Q3 | $393K | Buy |
3,244
+196
| +6% | +$23.8K | 0.08% | 260 |
|
|
2023
Q2 | $349K | Sell |
3,048
-1,065
| -26% | -$122K | 0.07% | 301 |
|
|
2023
Q1 | $567K | Buy |
4,113
+1,829
| +80% | +$252K | 0.16% | 128 |
|
|
2022
Q4 | $296K | Buy |
+2,284
| New | +$296K | 0.29% | 72 |
|